Avalo Therapeutics Inc (AVTX)
15.40
+0.42
(+2.80%)
USD |
NASDAQ |
Apr 26, 14:28
Avalo Therapeutics Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 14.12M |
| March 31, 2023 | 19.77M |
| December 31, 2022 | 19.42M |
| September 30, 2022 | 19.07M |
| June 30, 2022 | 18.71M |
| March 31, 2022 | 33.18M |
| December 31, 2021 | 32.83M |
| September 30, 2021 | 32.48M |
| June 30, 2021 | 17.14M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | 15.30M |
| June 30, 2019 | 15.33M |
| March 31, 2019 | 15.35M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 15.40M |
| June 30, 2018 | 15.43M |
| March 31, 2018 | 15.38M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.6076M |
| March 31, 2017 | 1.492M |
| December 31, 2016 | 2.354M |
| September 30, 2016 | 3.190M |
| June 30, 2016 | 4.002M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
33.18M
Maximum
Mar 2022
12.49M
Average
15.30M
Median
Sep 2019
Total Long Term Debt (Quarterly) Benchmarks
| Imunon Inc | -- |
| iBio Inc | -- |
| Kodiak Sciences Inc | -- |
| Petros Pharmaceuticals Inc | 8.014M |
| Ocugen Inc | 2.80M |